Clinical Trials Directory

Trials / Unknown

UnknownNCT03200743

Catestatin and Hypertension in Pregnancy

Relationship Between Catestatin and Pregnant Hypertensive Disorders

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Yuchen Pan · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Catestatin is a kind of protein involved with cardiovascular disease. Accumulated evidence shows that Catestatin may be a predictor of primary hypertension, but whether it plays the same role in pregnant hypertensive disorders needs to be determined. By measuring the plasma level of Catestatin, main biochemical marks and UCG in healthy pregnancy and pregnancy with hypertension, the research may contribute to this problem.

Conditions

Timeline

Start date
2017-05-14
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2017-06-27
Last updated
2017-06-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03200743. Inclusion in this directory is not an endorsement.

Catestatin and Hypertension in Pregnancy (NCT03200743) · Clinical Trials Directory